LifeMD, Inc. (LFMD)

LifeMD Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	234.01	212.45	152.55	119.03	92.88	37.29
Revenue Growth (YoY)	43.07%	39.27%	28.16%	28.16%	149.04%	199.10%
Cost of Revenue	28.11	24.07	18.9	18.67	18	8.86
Gross Profit	205.9	188.39	133.65	100.37	74.88	28.43
Selling, General & Admin	195.28	187.1	136.64	131.23	124.96	84.74
Research & Development	10.1	9.51	6.06	2.97	0.95	0.45
Other Operating Expenses	7.95	7.92	5.44	5.85	3.27	1.07
Operating Expenses	213.33	204.53	148.14	140.05	129.18	86.25
Operating Income	-7.43	-16.14	-14.49	-39.69	-54.3	-57.82
Interest Expense	-2.33	-2.18	-2.6	-1.28	-3.02	-1.67
EBT Excluding Unusual Items	-9.76	-18.33	-17.09	-40.96	-57.32	-59.49
Impairment of Goodwill	-	-	-	-8	-	-
Asset Writedown	-	-	-	-0.86	-	-
Other Unusual Items	-	-	-0.33	5.16	-4	-0.91
Pretax Income	-9.76	-18.33	-17.41	-44.66	-61.32	-60.4
Income Tax Expense	0.4	0.4	0.43	0.36	0.01	0.12
Earnings From Continuing Operations	-10.16	-18.73	-17.84	-45.02	-61.32	-60.52
Net Income to Company	-10.16	-18.73	-17.84	-45.02	-61.32	-60.52
Minority Interest in Earnings	-0.57	-0.15	-2.76	-0.51	0.43	1.88
Net Income	-10.73	-18.88	-20.6	-45.54	-60.9	-58.65
Preferred Dividends & Other Adjustments	3.11	3.11	3.11	3.11	0.87	4.72
Net Income to Common	-13.83	-21.99	-23.7	-48.64	-61.77	-63.36
Shares Outstanding (Basic)	42	41	34	31	27	14
Shares Outstanding (Diluted)	42	41	34	31	27	14
Shares Change (YoY)	17.81%	21.50%	9.46%	14.69%	89.20%	44.23%
EPS (Basic)	-0.33	-0.53	-0.70	-1.57	-2.29	-4.44
EPS (Diluted)	-0.33	-0.53	-0.70	-1.57	-2.29	-4.44
Free Cash Flow	13.94	16.02	8.62	-23.3	-33.33	-12.13
Free Cash Flow Per Share	0.33	0.39	0.25	-0.75	-1.23	-0.85
Gross Margin	87.99%	88.67%	87.61%	84.32%	80.62%	76.24%
Operating Margin	-3.17%	-7.60%	-9.50%	-33.34%	-58.47%	-155.04%
Profit Margin	-5.91%	-10.35%	-15.54%	-40.86%	-66.51%	-169.90%
Free Cash Flow Margin	5.96%	7.54%	5.65%	-19.58%	-35.89%	-32.53%
EBITDA	-5.86	-14.67	-13.31	-38.6	-53.95	-57.48
EBITDA Margin	-2.51%	-6.91%	-8.73%	-32.43%	-58.08%	-154.14%
D&A For EBITDA	1.57	1.47	1.18	1.09	0.36	0.34
EBIT	-7.43	-16.14	-14.49	-39.69	-54.3	-57.82
EBIT Margin	-3.17%	-7.60%	-9.50%	-33.34%	-58.47%	-155.04%
Revenue as Reported	234.01	212.45	152.55	119.03	92.88	37.29

Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q